PRINCIPAL: ESTUDIO OBSERVACIONAL PROSPECTIVO DE MODELOS DE TRATAMIENTO Y RESULTADOS DEL TRATAMIENTO EN EL MUNDO REAL EN PACIENTES CON CARCINOMA DE CÉLULAS RENALES AVANZADO O METASTÁSICO QUE RECIBEN PAZOPANIB.
Dades bàsiques
- Protocol:
- GLA-PAZ-2012-01
- EURDRACT:
- NCT:
- Centre:
- Any inici:
- 2014
- Any de finalització:
Documents
- No hi ha documents
Participants
Finançadors - Promotors
GLAXOSMITHKLINE S.A.
Resultats de l'Assaig Clínic
Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice.
Diaz Beveridge R; (...); Montalar J
Article. 10.6092/1590-8577/1570. 2014
Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience
Diaz-Beveridge, R; (...); JORGE APARICIO URTASUN
Article. 10.1097/MPH.0000000000000339. 2015
Podocalyxin-like protein 1 is a relevant marker for human c-kit(pos) cardiac stem cells
Moscoso I; (...); Bernad A
Article. 10.1002/term.1795. 2016
Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience
Berlanga, Pablo; (...); Castel, Victoria
Article. 10.1097/MPH.0000000000000546. 2016
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Article. 10.1080/10428194.2018.1474462. 2019
Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
Imedio ER; (...); Salcedo JM
Article. 10.1007/s12032-014-0948-x. 2014